Ms. Dao Thuy Ha of Traphaco JSC receives the National Brand Award
Traphaco’s Board of Directors (TRA) has appointed Ms. Dao Thuy Ha as the new CEO, replacing Mr. Tran Tuc Ma, effective November 10, 2025. Previously, on November 5, the Board approved Mr. Ma’s resignation due to personal reasons.
Ms. Dao Thuy Ha, the new CEO of Traphaco, joined the company in 1996 and has nearly 30 years of experience across various roles in market planning, R&D, and new product development.
Ms. Dao Thuy Ha, Traphaco’s new CEO. Photo: Traphaco
Prior to her appointment, Ms. Ha served as Deputy CEO in charge of Sales and Marketing, a key area contributing to Traphaco’s growth in the recent quarter.
Ms. Ha is recognized as a key figure in implementing Traphaco’s “dual development strategy,” focusing on both traditional and modern pharmaceuticals, alongside international technology transfer and digital transformation.
Leadership Change Amid Profit Growth
The new appointment follows Traphaco’s Q3 2025 financial report, which showed significant business growth.
In Q3, TRA recorded VND 676 billion in net revenue, a 20% increase year-over-year. Cost of goods sold rose only 4%, resulting in a 34% increase in gross profit to nearly VND 400 billion.
During the period, selling expenses increased by 36% to VND 226 billion, while administrative expenses slightly decreased to VND 80 billion. The rise in selling expenses is attributed to the company’s efforts to boost sales of key products and expand its pharmacy network.
After deducting expenses, Traphaco reported an after-tax profit of VND 78.2 billion, a 79% increase compared to the same period in 2024.
According to Traphaco, the profit growth is a result of increased product sales, optimized product mix, and expanded pharmacy network—areas Ms. Ha oversaw in her previous role.
In the first nine months of 2025, Traphaco achieved VND 1,935 billion in revenue (up 12%) and VND 201 billion in after-tax profit (up 14%). These results represent 76% of the annual revenue target and 75% of the profit target.
In her new role, Ms. Dao Thuy Ha will lead Traphaco in continuing to execute its strategy of strengthening the modern pharmaceutical segment. The company currently operates four factories and maintains a strategic partnership with Daewoong (South Korea). This collaboration has enabled Traphaco to adopt advanced production technology, shorten R&D timelines, and launch 12 bioequivalent drugs, aiming to increase domestic supply.
Traphaco Appoints First Female CEO in Over a Decade
With over 30 years of dedicated service at Traphaco JSC (HOSE: TRA), Mrs. Dao Thuy Ha has been appointed as the new CEO, succeeding Mr. Tran Tuc Ma, who steps down after 15 years in the role but remains on the company’s Board of Directors.
Peace Corporation Sitting on Hundreds of Billions in Cash, Yet Still Delaying Debt Payments
As of September 30, Hòa Bình Construction Group held over 319 billion VND in cash. However, by October 31, the company defaulted on a principal payment of more than 12 billion VND for its HBCH2225002 bond issuance, citing inability to secure sufficient funds as the reason.
Top 15 Profit-Soaring Companies in Q3 2025: Minimum 540% Growth, with One Firm Skyrocketing 5,700%—Real Estate Dominates the List
The top-performing businesses in the first nine months of 2025 showcase remarkable growth, with the real estate sector leading the charge and boasting the highest number of representatives. Notably, several companies have turned their fortunes around, transitioning from losses to impressive profits.
An Binh Securities Appoints New CEO
An Binh Securities has appointed Mr. Nguyen Quang Dat as its Chief Executive Officer for a two-year term, effective November 1, 2025.
Sonadezi Surpasses Annual Plan with Over $1 Billion Profit in 9 Months
Following a record-breaking second quarter, Sonadezi’s net profit continued its upward trajectory in Q3 2025, driven by steady growth in port services, clean water, and improved gross margin. The company has already surpassed its full-year profit target after just three quarters.
